Comparison of [3H]progesterone and [6,7-3H]-17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione for the measurement of progesterone receptors in human malignant tissue.
D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000032:analysis*; D003600:Cytosol / Q000032:analysis; D005260:Female; D005833:Genital Neoplasms, Female / Q000032:analysis*; D005990:Glycerol; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008722:Methods; D009649:Norpregnadienes / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism*; D045167:Progesterone Congeners / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000032:analysis* / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism; D014156:Transcortin / Q000378:metabolism
D009649:Norpregnadienes; D045167:Progesterone Congeners; D011980:Receptors, Progesterone; D012709:Serum Albumin; D011374:Progesterone; D014156:Transcortin; D005990:Glycerol; D006854:Hydrocortisone